产前诊断前置血管妊娠的围产结局:系统综述与荟萃分析
系统综述与荟萃分析纳入21项研究、683例产前诊断前置血管妊娠,围产存活率合并估计为98.6%(95%CI 97.6-99.3%)。7项比较研究显示,未产前诊断者围产存活率72.1% vs 产前诊断者98.6%,未诊断者围产死亡风险为诊断者的25.39倍(OR 25.39,95%CI 7.93-81.31,P<0.0001),缺氧相关发病率风险增加50倍(OR 50.09,95%CI 17.33-144.79)。
要点
- 产前诊断前置血管者围产存活率合并估计98.6%(95%CI 97.6-99.3%)。
- 未产前诊断者围产死亡风险为诊断者的25.39倍(OR 25.39,95%CI 7.93-81.31)。
- 未产前诊断者缺氧相关发病率风险为诊断者的50.09倍(OR 50.09,95%CI 17.33-144.79)。
核心结论
- 产前诊断前置血管与高围产存活率相关,而缺乏产前诊断显著增加围产死亡和缺氧相关发病风险。
- 作者认为应进一步研究将前置血管产前筛查纳入常规临床实践的策略。
研究设计与样本
- 系统综述与荟萃分析,检索MEDLINE、EMBASE和Cochrane Library,纳入提供前置血管妊娠围产结局的前瞻性和回顾性队列及人群研究。
- 共纳入21项研究、683例产前诊断前置血管妊娠;采用随机效应模型合并估计围产存活率和完整围产存活率,采用发生率差荟萃分析比较产前诊断与未诊断病例的合并比例差异。
- 异质性采用Cochran Q检验和I²统计量评估。
主要发现
- 产前诊断前置血管妊娠中,死产3例(1.01%,95%CI 0.40-1.87%)、新生儿死亡5例(1.19%,95%CI 0.52-2.12%)、存活新生儿675例,围产存活率合并估计98.6%(95%CI 97.6-99.3%)。
- 7项包含产前诊断与未诊断病例的研究中,未产前诊断者围产存活率72.1%(95%CI 50.6-89.4%,61/118)vs 产前诊断者98.6%(95%CI 96.7-99.7%,224/226)。
- 未产前诊断者围产死亡风险为产前诊断者的25.39倍(OR 25.39,95%CI 7.93-81.31,P<0.0001)。
- 未产前诊断者缺氧相关发病率风险为产前诊断者的50.09倍(OR 50.09,95%CI 17.33-144.79;36/61 vs 5/224)。
- 未产前诊断者完整围产存活率28.1%(95%CI 14.1-44.7%)vs 产前诊断者96.7%(95%CI 93.6-98.8%),发生率差73.4%(95%CI 53.9-92.7%;Z=-7.4066,P<0.001)。
临床怎么用
- 原文结论指出产前诊断前置血管与高围产存活率相关,缺乏产前诊断显著增加围产死亡和缺氧相关发病风险。
- 作者建议进一步研究将前置血管产前筛查纳入常规临床实践的策略。
局限性
- 作者指出需进一步研究将前置血管产前筛查纳入常规临床实践的策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To derive accurate estimates of perinatal survival in pregnancies with and without a prenatal diagnosis of vasa previa based on a systematic review of the literature and meta-analysis. METHODS: A search of MEDLINE, EMBASE and The Cochrane Library was performed to review relevant citations reporting on the perinatal outcomes of pregnancies with vasa previa. We included prospective and retrospective cohort and population studies that provided data on pregnancies with a prenatal diagnosis of vasa previa or cases diagnosed at birth or following postnatal placental examination. Meta-analysis using a random-effects model was performed to derive weighted pooled estimates of perinatal survival (excluding stillbirths and neonatal deaths) and intact perinatal survival (additionally excluding hypoxic morbidity). Incidence rate difference (IRD) meta-analysis was used to estimate the significance of differences in pooled proportions between cases of vasa previa with and those without a prenatal diagnosis. Heterogeneity between studies was estimated using Cochran's Q and the I2 statistic. RESULTS: We included 21 studies reporting on the perinatal outcomes of 683 pregnancies with a prenatal diagnosis of vasa previa. There were three stillbirths (1.01% (95% CI, 0.40-1.87%)), five neonatal deaths (1.19% (95% CI, 0.52-2.12%)) and 675 surviving neonates, resulting in a pooled estimate for perinatal survival of 98.6% (95% CI, 97.6-99.3%). Based on seven studies that included cases of vasa previa with and without a prenatal diagnosis, the pooled perinatal survival in pregnancies without a prenatal diagnosis (61/118) was 72.1% (95% CI, 50.6-89.4%) vs 98.6% (95% CI, 96.7-99.7%) in cases with a prenatal diagnosis (224/226). Therefore, the risk of perinatal death was 25-fold higher when a diagnosis of vasa previa was not made antenatally, compared with when it was (odds ratio (OR), 25.39 (95% CI, 7.93-81.31); P < 0.0001). Similarly, the risk of hypoxic morbidity was increased 50-fold in cases with vasa previa without a prenatal diagnosis compared with those with a prenatal diagnosis (36/61 vs 5/224; OR, 50.09 (95% CI, 17.33-144.79)). The intact perinatal survival rate in cases of vasa previa without a prenatal diagnosis was significantly lower than in those with a prenatal diagnosis (28.1% (95% CI, 14.1-44.7%) vs 96.7% (95% CI, 93.6-98.8%)) (IRD, 73.4% (95% CI, 53.9-92.7%); Z = -7.4066, P < 0.001). CONCLUSIONS: Prenatal diagnosis of vasa previa is associated with a high rate of perinatal survival, whereas lack of an antenatal diagnosis significantly increases the risk of perinatal death and hypoxic morbidity. Further research should be undertaken to investigate strategies for incorporating prenatal screening for vasa previa into routine clinical practice. © 2020 The Authors. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.
引用
- Zhang W, Geris S, Al-Emara N, et al. Perinatal outcome of pregnancies with prenatal diagnosis of vasa previa: systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2021. PMID: 32735754. doi:10.1002/uog.22166
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。